mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |